Newland Pharmaceutical Awarded CEP Certificate for Moxifloxacin Hydrochloride API
Release Date:2026-09-21 11:26:17 Views:207
Recently, our company received the Certificate of Suitability to Monograph of European Pharmacopoeia (CEP Certificate) for Moxifloxacin Hydrochloride API, issued by the European Directorate for the Quality of Medicines & HealthCare (EDQM). The CEP Certificate is an authoritative certification from the EDQM confirming that an API's quality complies with European Pharmacopoeia standards. It is widely recognized by all EU member states, as well as Canada, Australia, New Zealand, and other countries that have signed bilateral agreements.

What is the CEP Certificate?
The CEP Certificate, formally known as the Certificate of Suitability to Monograph of European Pharmacopoeia, is a key quality credential for APIs entering the EU and other regulated markets. It certifies that the API's quality control, manufacturing process, and quality management system fully comply with the requirements of the European Pharmacopoeia.
Significance of the Certification
The approval of the CEP Certificate for Moxifloxacin Hydrochloride API marks that the company's quality system, manufacturing process, and quality research data for this product all comply with the requirents of the European Pharmacopoeia, providing important qualification support for the company's further expansion into the EU and global regulated markets.
As a manufacturer of Moxifloxacin Hydrochloride API, obtaining this CEP Certificate demonstrates that the company's production and quality management level has been certified by the EDQM. This also represents the latest progress in the company's ongoing efforts to build an internationalized quality system.
Future Direction
The company will continue to advance its internationalization strategy, relying on its established API R&D and manufacturing platform to continuously optimize product quality systems, and provide global partners with API products that meet international standards.
We look forward to working with you to create value together.